N/A UNCHANGED Last Price Updated: 8:00 PM EDT, Jul 27, 2018 Add to My Watchlist
Stories about DB G10 Currency Harvest Fund PS
Profiling Correlations: Alternative Strategies - Part 2
April 04, 2018
Low and negative correlations alone aren’t always a silver bullet, of course. The trick is finding strategies that offer substantial diversification benefits vs. conventional stock and bond funds with...
BRIEF-DBV Technologies Announces Results From Phase II Study Of Viaskin Milk In Milk-Allergic Patients
February 26, 2018
Best And Worst ETFs Of Last Week
February 12, 2018
Against such a volatile backdrop, last week a few ETFs saw a huge spike while several were laggards.
BRIEF-DBV Technologies peanut allergy treatment fails to meet main goal in late-stage study
October 20, 2017
* DBV Technologies announces topline results of phase III clinical trial in peanut-allergic patients four to 11 years of age??
DBV Technologies peanut allergy drug fails key study
October 20, 2017
Oct 20 (Reuters) - Drug developer DBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study.
BRIEF-Doubleview Capital Corp receives alleged notice of default on convertible debenture
August 16, 2017
BRIEF-Doubleview announces resignation of CFO
July 13, 2017
Best and Worst Performing Alternative ETFs
May 25, 2017
Alternative investments are supposed to diversify overall portfolio risk by providing uncorrelated returns. Ideally, adding an alternative allocation to more traditional investment exposures enhances...
How Smart Beta Works for Other Asset Classes - Part 1
December 13, 2016
Smart beta exchange-traded funds (ETFs) have become increasingly popular over the past several years. In fact, BlackRock projects that smart beta ETFs will grow at a 20% annual pace to $1 trillion in...
* Topline results from two-year follow-up study of Viaskin Peanut show long-lasting and high levels of desensitization to peanut
BRIEF-DBV Technologies says FDA gives fast track status to Viaskin Milk
September 20, 2016
* Results of phase I/II clinical study of Viaskin Milk should be presented in H2 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
VGK, DBV: Big ETF Outflows
September 15, 2016
Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the Vanguard FTSE Europe ETF (VGK), where 7,396,067 units were...
An ETF Capitalizing on Forex Market Carry Trade Opportunities
August 31, 2016
Currency traders have been raking in a tidy profit by capitalizing on the spread between record low yields in some developed markets and higher yields in other areas. Investors can also benefit from...
Rethinking Bond ETFs: Unbundle and Rebuild
July 26, 2016
By Corey Hoffstein With the benefit of hindsight, there have been few investments as attractive as core U.S. fixed income over the last 30 years. Capital preservation, income, diversification, and even...
June 1 (Reuters) - Switzerland's AC Immune, which already has money in hand from Roche for its most advanced drug, is planning a share sale in the United States to raise up to $50 million for separate...
LONDON, May 31 (Reuters) - Nestle, the world's biggest food company, is stepping up its push into medicine with a global deal worth up to 100 million euros ($111 million) to develop and market an...
35 A+ Currency ETFs to Track Global Forex Moves
May 10, 2016
The foreign exchange market, or forex, is the largest, most liquid financial market in the world. Investors can easily track currency moves through exchange traded funds (ETFs). Investors who want...
Biotech companies chase elusive peanut allergy treatment
October 27, 2015
Oct 27 (Reuters) - A few months ago, Jenessa Torres watched her son erupt in hives after he licked a piece of nutty chocolate. She hadn't known that her 3-year-old was one of the million American...
Defence in, oil out in French stock index fashion stakes
August 14, 2015
PARIS, Aug 14 (Reuters) - Dassault Aviation, maker of the Rafale military fighter plane that is enjoying export success this year, is set for promotion to the SBF120 index of top French stocks in a...
PRESS DIGEST- Financial Times - June 23
June 22, 2015
June 23 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
IVV, DBV: Big ETF Outflows
June 09, 2015
Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the iShares Core S&P 500 ETF (IVV), where 3,650,000 units were...
DBV Crowded With Sellers
June 01, 2015
In trading on Monday, shares of the PowerShares DB G10 Currency Harvest Fund ETF (DBV) entered into oversold territory, changing hands as low as $24.11 per share. We define oversold territory using the...
(DBV) Shares Cross Above 200 DMA
April 16, 2015
In trading on Thursday, shares of the ETF (DBV) crossed above their 200 day moving average of $25.43, changing hands as high as $25.44 per share. shares are currently trading up about 0.3% on the...
BRIEF-DBV Technologies receives FDA breakthrough therapy designation for Viaskin peanut
April 08, 2015
* Receives FDA breakthrough therapy designation for Viaskin peanut for the treatment of peanut allergy in children
More ETF Ideas for Global Currency Wars
March 23, 2015
The PowerShares DB U.S. Dollar Index Bullish Fund (NYSEArca: UUP) fell nearly 2% last week, but with the Federal Reserve on course to raise interest rates in the coming months and other developed...
PowerShares Reopens 11 ETFs for new Creations
February 26, 2015
Invesco’s (NYSE: IVZ) PowerShares unit, the fourth-largest U.S. issuer of exchange traded funds, said it has it resumed accepting new creation orders in 11 ETFs that were temporarily subject to...
PowerShares Halts Creations in 11 ETFs, Including U.S. Dollar Funds
February 25, 2015
Invesco’s (NYSE: IVZ) PowerShares unit, the fourth-largest U.S. issuer of exchange traded funds, said Wednesday it is temporarily halting creations of new shares of in 11 ETFs, including the...